Back to search

National and Kapodistrian University of Athens

Η επίπτωση του πολυμορφισμού Ala379Val του γονιδίου της σχετιζόμενης με τις λιποπρωτεΐνες φωσφολιπάσης Α2 σε ασθενείς με υπέρταση: η επίδρασή του στη φλεγμονή και στην αιμόσταση

Abstract

dc:description

Background: Lipoprotein-associated phospholipase A2 is an independent risk predictor for cardiovascular disease. While it has also been proposed as an inflammatory biomarker, the role of this enzyme in inflammation has been ambiguous. Several polymorphisms of the Lp-PLA2 gene have been associated with cardiovascular health and disease. We examined the prevalence of Ala379Val polymorphism on hypertensive patients, as well as its impact on inflammatory and thrombotic markers. Methods: We enrolled 364 male subjects; 182 subjects with essential arterial hypertension and 182 controls. Genotyping for the Ala379Val variant was detected by polymerase-chain reaction. In a subgroup of 125 hypertensive patients, we also examined the relationship between genotype distribution and inflammatory and thrombotic markers. Plasma levels of VCAM-1, tPA, PAI-1 and fibrinogen were determined. Results: The genotype distribution in the overall population was: Val/Val: 15 (4.1%), Ala/Val: 123 (33.8%), Ala/Ala: 226 (62.1%). Genotype distribution in the subgroup of 125 subjects was: Val/Val: 4 (3.2%), Ala/Val: 39 (31.2%), Ala/Ala: 82 (65.6%). Valine carriers had significantly lower risk for arterial hypertension (OR= [95%CI]: 0.627[0.426-0.924], P=0.018). The presence of Alanine was not associated with hypertension (P=NS). Valine homozygotes had lower levels of fibrinogen compared to other genotypes (P=0.041). In multivariable analysis Ala/Val genotype was independently associated with significantly lower risk for arterial hypertension in the overall population, compared to Ala/Ala and Val/Val genotypes that signified an equal probability of hypertension [OR=(95%CI):0.486(0.279-0.847), P=0.011]. Among hypertensives, an independent association was established between Ala/Val genotype and elevated fibrinogen levels [B (95% CI): 0.786 (0.078, 1.494), P=0.03]. The presence of Valine variant was not associated with VCAM-1, tPA or PAI-1 (P=NS for all). Conclusions: While the Ala/Val genotype of the Ala379Val polymorphism of Lp-PLA2 is associated with decreased risk for hypertension, it is also associated with elevated fibrinogen levels in hypertensives, indicating activated systemic inflammatory and thrombotic status. These findings suggest that this polymorphism significantly contributes to the process of inflammation and thrombosis in patients with essential hypertension.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kardara, Despoina
  • Καρδαρά, Δέσποινα

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27854

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kardara, Despoina; Καρδαρά, Δέσποινα. Η επίπτωση του πολυμορφισμού Ala379Val του γονιδίου της σχετιζόμενης με τις λιποπρωτεΐνες φωσφολιπάσης Α2 σε ασθενείς με υπέρταση: η επίδρασή του στη φλεγμονή και στην αιμόσταση. National and Kapodistrian University of Athens, 2011. http://hdl.handle.net/10442/hedi/27854